Moomoo AI 已提取核心信息
Canopy Growth Corporation, a leading company in the cannabis industry, has been informed by the United States Securities and Exchange Commission (SEC) that its recent Registration Statement on Form S-1, filed on January 26, 2024, will not undergo review by the agency. The SEC's communication, dated January 31, 2024, was addressed to David Klein, CEO of Canopy Growth, and clarified that the responsibility for the accuracy and adequacy of disclosures in the registration statement lies with the company and its management. The SEC also referenced Rules 460 and 461, which pertain to requests for acceleration of the registration process. Canopy Growth has been advised to contact Alan Campbell from the SEC's Division of Corporation Finance, Office of Life Sciences, for any further inquiries.
Canopy Growth Corporation, a leading company in the cannabis industry, has been informed by the United States Securities and Exchange Commission (SEC) that its recent Registration Statement on Form S-1, filed on January 26, 2024, will not undergo review by the agency. The SEC's communication, dated January 31, 2024, was addressed to David Klein, CEO of Canopy Growth, and clarified that the responsibility for the accuracy and adequacy of disclosures in the registration statement lies with the company and its management. The SEC also referenced Rules 460 and 461, which pertain to requests for acceleration of the registration process. Canopy Growth has been advised to contact Alan Campbell from the SEC's Division of Corporation Finance, Office of Life Sciences, for any further inquiries.
美国证券交易委员会（SEC）已告知大麻行业的领先公司Canopy Growth Corporation，其最近于2024年1月26日提交的S-1表格注册声明不会经过该机构的审查。美国证券交易委员会于2024年1月31日致函Canopy Growth首席执行官戴维·克莱因，并澄清说，注册声明中披露的准确性和充分性由公司及其管理层负责。美国证券交易委员会还引用了与加快注册程序的请求有关的第460和461条。已建议Canopy Growth联系美国证券交易委员会生命科学办公室公司财务部的艾伦·坎贝尔，进行进一步的查询。
美国证券交易委员会（SEC）已告知大麻行业的领先公司Canopy Growth Corporation，其最近于2024年1月26日提交的S-1表格注册声明不会经过该机构的审查。美国证券交易委员会于2024年1月31日致函Canopy Growth首席执行官戴维·克莱因，并澄清说，注册声明中披露的准确性和充分性由公司及其管理层负责。美国证券交易委员会还引用了与加快注册程序的请求有关的第460和461条。已建议Canopy Growth联系美国证券交易委员会生命科学办公室公司财务部的艾伦·坎贝尔，进行进一步的查询。
有用
没用